skin pigmentation: nootropics and compounds | sci-wiki

Glutathione + Kojic Acid + Glycolic Acid

Glutathione, kojic acid, and glycolic acid is a three-ingredient combination used in cosmetic skin-lightening and brightening formulations. It joins two agents that reduce melanin production, the antioxidant peptide glutathione and the tyrosinase inhibitor kojic acid, with glycolic acid, an alpha-hydroxy acid that exfoliates the surface of the skin. The blend is designed to fade hyperpigmentation and improve skin tone and texture by combining pigment-reducing and exfoliating actions.

1 outlet

Blend

Hydroquinone + Tretinoin + Fluocinolone Acetonide

Hydroquinone + Tretinoin + Fluocinolone Acetonide is a triple-combination topical cream used to treat melasma, a chronic facial hyperpigmentation. It brings together a depigmenting agent (hydroquinone), a retinoid (tretinoin) and a low-potency corticosteroid (fluocinolone acetonide) in a single formulation. Marketed in the United States as Tri-Luma and rooted in the older Kligman formula, it is widely regarded as one of the most effective topical treatments for melasma.

1 outlet

Blend

Hydroquinone + Tretinoin + Mometasone

Hydroquinone + Tretinoin + Mometasone is a triple-combination topical cream used to lighten melasma and other facial hyperpigmentation. It is a modified version of the classic Kligman formula, pairing the depigmenting agent hydroquinone and the retinoid tretinoin with mometasone, a stronger corticosteroid than the fluocinolone used in the original. The formulation is widely prescribed and sold in some regions, though the more potent steroid raises particular safety concerns.

1 outlet

Peptide

Decapeptide-12

Decapeptide-12 is a synthetic peptide made of ten amino acids that is used in cosmetic skincare as a skin-brightening agent, best known under the trade name Lumixyl. It works by inhibiting tyrosinase, the enzyme that controls the pace of melanin production, and was developed as a gentler alternative to the traditional lightening agent hydroquinone. Applied to the skin, usually as part of a multi-step brightening routine, it has been studied mainly for melasma and other forms of facial hyperpigmentation. It is regulated as a cosmetic ingredient rather than a drug, and the clinical evidence for it comes from a small number of studies.

reference